Research Study

ResistAid™ from Lonza to enhance immune response – Download new publication now!

Published

Format: PDF file | Document type: Research Study

ResistAid™ from Lonza to enhance immune response – Download new publication now!

New research demonstrates the ability of ResistAid™, Lonza’s proprietary, arabinogalactan-based immune support ingredient, to increase the antibody response in healthy adults after exposure to the Tetanus vaccine. Conducted at a dosage of 1.5 g/day, the study finds the efficacy of ResistAid™ at a significantly lower dosage, as compared to the 4.5 g/day that was previously found to be effective. The findings are published in the Journal of the American College of Nutrition​, and can be found here: http://www.tandfonline.com/doi/full/10.1080/07315724.2013.839907​.

Related resources from Lonza Ltd

Show more

Supplier info centre